Anti-Kappa recognizes surface immunoglobulin on normal and neoplastic B-cells, and has been indicated as a potential aid in the identification of leukemias, plasmacytomas, and certain non-Hodgkin’s lymphomas, where the expression of a single light chain class is restricted. The determination of light chain ratio is critical in evaluating B-cell neoplasms, as the majority of B-cell lymphomas express either kappa or lambda light chains, while a mixture of kappa and lambda is characteristic of reactive proliferations. In paraffin-embedded tissue, Anti-Kappa displays strong staining of kappa-positive plasma cells, as well as cells that have absorbed exogenous immunoglobulins.


  • Available Formats:

    0.1 ml Concentrate - IHC610-100

    1.0 ml Concentrate - IHC610-1

    7.0 ml Pre-Dilute - IHC610-7




    Source Mouse Monoclonal
    Positive Control Tonsil
    Dilution Range 1:50-1:200


    1. Bray M, et al. Am J Clin Pathol. 1983; 80:526-8.
    2. Ashton-Key M, et al. Histopathology. 1996; 29:525-31.
    3. Kurtin PJ, et al. Am J Clin Pathol. 1999; 112:319-29.
    4. Falini B, et al. J Histochem Cytochem. 1982; 30:21-6.
    5. Marshall-Taylor CE, et al. Appl Immunohistochem Mol Morphol. 2002; 10:258-62.
    6. Sobol RE, et al. Clin Immunol Immunopathol. 1982; 24:139 -44.
    7. Samoszuk MK, et al. Diagn Immunol. 1985; 3:133-8.
    8. Abbondanzo SL, et al. Ann Diagn Pathol. 1999; 3:318-27.

Follow Us

  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle

Subscribe to receive our latest promotions and updates

Contact Us

#1 - 3691 Viking Way

Richmond, BC V6V 2J6

[email protected]

[email protected]

[email protected]

(604) 244-9962

Copyright © 2019 GenomeMe